Physician profile
Howard E Herrell
NPI 1043404601
$853.36
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347 · 2020: $118 · 2021: $194 · 2022: $154 · 2024: $40.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $40.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $40.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $148.19 | 2019-2021 | |
| Novo Nordisk INC | $115.38 | 2021 | |
| Abbvie INC. | $90.63 | 2019-2022 | |
| Mdd US Operations, LLC | $85.08 | 2019 | |
| Abbott Laboratories | $83.80 | 2020 | |
| Coloplast Corp | $60.55 | 2022 | |
| Astellas Pharma US INC | $59.62 | 2019-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $50.05 | 2019 | |
| Merck Sharp & Dohme LLC | $35.86 | 2019-2020 | |
| Becton, Dickinson and Company | $28.00 | 2022 | |
| Avion Pharmaceuticals | $24.76 | 2019 | |
| Daiichi Sankyo INC. | $23.08 | 2020 | |
| Boston Scientific Corporation | $19.35 | 2019 | |
| Allergan, INC. | $15.01 | 2019 | |
| Applied Medical Resources Corporation | $14.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Herrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.